Efficacy of the Pre-Admission Medication List (PAML) Builder Reminder Prompts (PAMLTIPS)

January 30, 2017 updated by: Alexander Turchin, Brigham and Women's Hospital

Effect of Reminder Prompts on Utilization of the PAML Builder Application Features

This project will study whether reminder prompts increase PAML Builder application feature utilization.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This project will study whether reminder prompts increase Pre-Admission Medication List (PAML) Builder application feature utilization. PAML Builder is an application designed and maintained by Partners Information Systems that assists clinicians in medication reconciliation - a process important for patient safety and quality of care. We have determined that several potentially helpful features of the application are not being utilized as frequently as had been expected. These features include:

  1. copying the pre-admission medication list (PAML) to the clipboard
  2. viewing the detailed audit trail of all changes made to the PAML
  3. sorting the list of medications obtained from other electronic sources by therapeutic class.

Reminder prompts (sometimes referred to as "Tip of the Day") have been employed to increase user awareness of underutilized application features. However, anecdotally some users find them unhelpful and potentially irritating. It is therefore important to determine whether reminder prompts accomplish the stated task of increasing application feature utilization. This project will compare PAML Builder application feature utilization before and after a pilot rollout of reminder prompts to determine whether they should be implemented permanently.

Study Type

Interventional

Enrollment (Actual)

14122

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Brigham and Women's Hospital
      • Boston, Massachusetts, United States, 02114
        • Massachusetts General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • users of the PAML Builder application (physicians, nurses, pharmacists)

Exclusion Criteria:

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: A
Receives the intervention (reminders displayed at the startup of the application) for both periods (period 1 and period 2) of the study.
Other: Reminders
Users of the PAML Builder application will receive reminders about three application features (copy/paste, audit trail, sort medications by class) at the startup of the application
Active Comparator: B
Receives the intervention (reminders displayed at the application startup) only during the second period (period 2) of the study.
Other: Reminders
Users of the PAML Builder application will receive reminders about three application features (copy/paste, audit trail, sort medications by class) at the startup of the application

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Difference in the change between combined frequency of utilization of all features promoted by the reminders per PAML built between the two arms from period 1 (intervention in one arm only) to period 2 (intervention in both arms).
Time Frame: The entire study period
The entire study period

Secondary Outcome Measures

Outcome Measure
Time Frame
Difference in the change between frequencies of utilization of the individual features promoted by the reminders per PAML built between the two arms from period 1 (intervention in one arm only) to period 2 (intervention in both arms).
Time Frame: The entire study period
The entire study period
Difference in the change between combined frequency of utilization of all features promoted by the reminders per PAML built between the two arms from period 1 to period 2 by the users who were displayed the corresponding reminder.
Time Frame: The entire study period
The entire study period
Difference in the change between frequencies of utilization of the individual features promoted by the reminders per PAML built between the two arms from period 1 to period 2 by the users who were displayed the corresponding reminders.
Time Frame: The entire study period.
The entire study period.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Brigham and Women's Hospital

Collaborators

Massachusetts General Hospital

Investigators

  • Principal Investigator: Alexander Turchin, MD, MS, Partners HealthCare
  • Principal Investigator: Carol Broverman, PhD, Partners HealthCare

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2008

Primary Completion (Actual)

July 1, 2008

Study Completion (Actual)

July 1, 2008

Study Registration Dates

First Submitted

April 9, 2008

First Submitted That Met QC Criteria

April 11, 2008

First Posted (Estimate)

April 14, 2008

Study Record Updates

Last Update Posted (Estimate)

January 31, 2017

Last Update Submitted That Met QC Criteria

January 30, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • PAMLTIPS

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe